Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole vs Exemestane on BMD in Breast Cancer
NCT00354302Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Apr 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by Canadian Cancer Trials Group. Started Apr 2006; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00354302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354302.